You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Loss of heterozigoty (LOH)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer, Gastric Cancer, Adenocarcinoma Trial in United States (Niraparib)

Recruiting
  • Esophageal Cancer
  • +2 more
  • Tampa, Florida
  • +3 more
Jan 18, 2023

Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

Not yet recruiting
  • Head and Neck Cancer
  • +8 more
  • Tumor and HLA Profiling
  • (no location specified)
Mar 31, 2023

HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

Completed
  • Epithelial Ovarian Cancer
  • +6 more
  • Evaluation of homologous recombination deficiency score
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022

A Training Set for the HRD Model in EOC

Recruiting
  • Epithelial Ovarian Cancer
  • +5 more
  • Homologous recombination deficiency model
  • Beijing, Beijing, China
    Lei Li
Dec 2, 2020

Mood Disturbance, Depressive Symptoms Trial in Jerusalem (LOH game- high dose, LOH game- low dose, LOH sham game)

Recruiting
  • Mood Disturbance
  • Depressive Symptoms
  • LOH game- high dose
  • +2 more
  • Jerusalem, Israel
    Computerized Neurotherapy Lab, School of OT, Hebrew University,
Jul 31, 2022

Premalignant Lesion, Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in France (Samples collection, Psychological and

Terminated
  • Premalignant Lesion
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Samples collection
  • +3 more
  • Annecy, France
  • +9 more
Oct 6, 2020

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (Rucaparib, Nivolumab)

Terminated
Has Results
  • Epithelial Ovarian Cancer
  • +4 more
  • Clovis, California
  • +4 more
May 19, 2021

Male Hypogonadism, Sexual Dysfunction Trial in Rome (D-chiroinositol)

Completed
  • Male Hypogonadism
  • Sexual Dysfunction
  • D-chiroinositol
  • Rome, Italy
    Clinica Alma Res
Mar 1, 2021

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma, Unknown Primary Trial in Liverpool (Versius Surgical System)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oropharynx
  • Squamous Cell Carcinoma, Unknown Primary
  • Versius Surgical System
  • Liverpool, United Kingdom
    Liverpool Head and Neck Centre, ENT Department Liverpool Univers
Oct 27, 2023

Overweight and Obesity Trial in Greenville (Weight loss plus self-compassion)

Not yet recruiting
  • Overweight and Obesity
  • Weight loss plus self-compassion
  • Greenville, North Carolina
    East Carolina University
Aug 3, 2023

Study of Skin Tumors in Tuberous Sclerosis

Recruiting
  • Tuberous Sclerosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Sarcoma Trial in Rome

    Recruiting
    • Sarcoma
      • Rome, Italy
        "Regina Elena" National Cancer Institute
      Oct 6, 2023

      Uncover Subtypes of Cancer Cachexia, LOTUS-CC Study

      Recruiting
      • Cancer Cachexia (CC)
        • Urbana, Illinois
        • +4 more
        Oct 3, 2023

        Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

        Not yet recruiting
        • Solid Tumor, Adult
        • +19 more
        • A2B694
        • xT CDx with HLA-LOH Assay
        • Duarte, California
        • +9 more
        Sep 22, 2023

        Abdominal Wall Defect, Hemorrhage, Bleeding Trial (Placebo, Tranexamic acid)

        Not yet recruiting
        • Abdominal Wall Defect
        • +2 more
        • Placebo
        • Tranexamic acid
        • (no location specified)
        Oct 11, 2023

        Obesity Trial (Usual care, SELF, STEP)

        Not yet recruiting
        • Obesity
        • Usual care
        • +2 more
        • (no location specified)
        Nov 21, 2023

        Osteoarthritis, Knee Trial in Australia, United States (Diet and Exercise)

        Not yet recruiting
        • Osteoarthritis, Knee
        • Diet and Exercise
        • Boston, Massachusetts
        • +3 more
        Jul 6, 2023

        Hemorrhage, Bleeding Trial (Placebo, Tranexamic acid)

        Not yet recruiting
        • Hemorrhage
        • Bleeding
        • Placebo
        • Tranexamic acid
        • (no location specified)
        Jul 6, 2023

        Drug Resistance in Immune Checkpoint Inhibitors of Non-small

        Recruiting
        • Non-Small Cell Lung Cancer
        • Anti-PD-1/PD-L1 monoclonal antibody
        • Shanghai, Shanghai, China
          Xiaomin Niu
        Jul 24, 2021

        Menstrual Iron Loss Using the Iron Isotope Dilution Technique

        Active, not recruiting
        • Iron-deficiency
        • +2 more
        • Iron isotope dilution
        • Alkaline hematin method
        • Zurich, Switzerland
          ETH Zurich
        Mar 28, 2023

        OVARIAN CANCER Trial in Worldwide (Cobimetinib, Niraparib, Atezolizumab)

        Recruiting
        • OVARIAN CANCER
        • Tucson, Arizona
        • +28 more
        Jan 10, 2023

        Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

        Not yet recruiting
        • Solid Tumor, Adult
        • +15 more
        • A2B530
        • xT-Onco with HLA-LOH Assay
        • Duarte, California
        • +6 more
        Feb 10, 2023

        Accidental Hypothermia, Emergencies Trial in Bergen (Wet clothing removal)

        Completed
        • Accidental Hypothermia
        • Emergencies
        • Wet clothing removal
        • Bergen, Norway
          Haukeland University Hospital
        Aug 10, 2023

        Obesity Trial (drug, dietary supplement, behavioral)

        Not yet recruiting
        • Obesity
        • IV bimagrumab
        • +4 more
        • (no location specified)
        Jun 27, 2023

        Weight Loss, Obesity Trial in Glasgow (Continuous Glucose Monitoring device)

        Recruiting
        • Weight Loss
        • Obesity
        • Continuous Glucose Monitoring device
        • Glasgow, United Kingdom
          University of Glasgow
        May 25, 2023